Search ASX code:
Generic filters

How did Integrated Research (ASX:IRI) shares react to its AGM?

Integrated Research Limited (ASX: IRI) shares have fallen after the company gave a trading update at its AGM.

AGM update

Integrated Research reminded investors about its performance during FY20. Revenue grew 10% to $110.9 million, net profit after tax (NPAT) grew 10% to $24.1 million and operating cashflow rose 14% to $24.2 million.

The FY20 net profit margin was the same and the dividends per share were maintained at 7.25 cents per share.

Asia Pacific revenue rose 17%, Europe revenue declined 1% and the Americas revenue increased slightly.

Trading update

Integrated Research commented that there’s a lot of economic uncertainty, COVID-19 is still affecting the northern hemisphere and there’s exchange rate volatility.

Its financial year to date revenue is lower than the prior corresponding period. The sales cycle has lengthened due to the current environment and there’s also a foreign currency exchange headwind.

However, the company said that a significant proportion of license sales occur in the last few weeks of the reporting period and there’s continuing currency volatility. The sales deferrals and currency swings may mean that first half revenue and net profit is less in the first half than the corresponding period.

Longer term opportunity

Integrated Research pointed out three market dynamics that will help its long term growth.

With ‘collaboration’ there is a shift to remote working. Around 500 million global workers are estimated to be remote in the 2021 calendar year – this represents 40% of knowledge workers. In 2020 there is 48% year on year growth of conferencing users.

In ‘transactions’ there is an accelerated shift to digital payments. Visa reported that their annual US transaction volumes are up 30% for online transactions excluding travel, whilst in-store is down 5%.

Finally, in ‘cloud’ the public cloud spending to accelerate to a compound annual growth rate of 18.8% over 2021 to 2024, after 6.1% growth in 2020.

Summary thoughts

Short term weaknesses can be an opportunity to buy businesses with long term growth potential. I think that Integrated Research is worth being a long term holding in a portfolio.

However, I don’t have as much conviction in it as much as other ASX growth shares like Pushpay Holdings Ltd (ASX: PPH).

1 ASX Stock to Buy RIGHT NOW...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: